Related Experiment Videos
Bacterial ghosts are an efficient delivery system for DNA vaccines
Thomas Ebensen1, Susanne Paukner, Claudia Link
1Vaccine Research Group, Division of Microbiology, Gesellschaft fuer Biotechnologische Forschung-German Research Centre for Biotechnology, Braunschweig, Germany.
Journal of Immunology (Baltimore, Md. : 1950)
|May 22, 2004
Summary
Bacterial ghosts effectively deliver DNA vaccines, enhancing immune responses and improving antigen presentation. This novel delivery system overcomes limitations of traditional DNA vaccines, offering a promising platform for improved immunogenicity.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- DNA vaccine efficacy is limited by high plasmid doses and poor immunogenicity.
- Developing effective DNA vaccine delivery systems is crucial for widespread implementation.
Purpose of the Study:
- To evaluate Mannheimia haemolytica ghosts as a delivery system for DNA vaccines.
- To assess the immunogenicity and antigen delivery capacity of bacterial ghosts.
Main Methods:
- In vitro studies: Bacterial ghosts loaded with pEGFP-N1 plasmid assessed for APC uptake and transfection rates.
- In vivo studies: BALB/c mice immunized with pCMVbeta-loaded ghosts via intradermal, intramuscular, or intravenous routes.
- Immune response analysis: Humoral and cellular immunity (CD4+, CD8+ T cells), Th1/Th2 response modulation, and dendritic cell activation were evaluated.
Main Results:
- Bacterial ghosts efficiently transfected APCs in vitro (52-60% transfection rate).
- Ghost-mediated DNA delivery induced stronger Ag-specific humoral and cellular immune responses compared to naked DNA.
- Bacterial ghosts modulated Th response towards a dominant Th2 pattern and promoted dendritic cell maturation and activation, acting as natural adjuvants.
Conclusions:
- Bacterial ghosts are a promising platform for developing more efficient DNA vaccines.
- They enhance DNA vaccine delivery to APCs, improve immunogenicity, and act as adjuvants.
- This technology can overcome current limitations in DNA vaccine implementation.